FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 2161220 · Received July 13, 2011

Report

Report Number
2124215-2011-08436
Event Type
Malfunction
Date Received
July 13, 2011
Date of Event
April 14, 2011
Report Date
April 14, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE LEAD WAS NOT RETURNED FOR TESTING. THEREFORE, BOSTON SCIENTIFIC CANNOT CONFIRM THE REPORTED CLINICAL OBSERVATIONS. NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS ISSUE WILL BE RE-EVALUATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS ATRIAL LEAD WAS EXHIBITING NOISE AND BIPOLAR IMPEDANCE MEASUREMENTS GREATER THAN 2500 OHMS. THE OUT OF RANGE IMPEDANCE MEASUREMENTS TRIGGERED THE LEAD SAFETY SWITCH (LSS) ON THE ASSOCIATED PACEMAKER. UNIPOLAR IMPEDANCE MEASUREMENTS WERE 500 OHMS AND THE LEAD WAS PROGRAMMED TO UNIPOLAR CONFIGURATION. ADDITIONALLY, NO SENSING MEASUREMENTS WERE OBSERVED FROM THIS LEAD WITH THE PACING SYSTEM ANALYZER (PSA). A REVISION PROCEDURE WAS PERFORMED AND THE LEAD WAS REMOVED FROM SERVICE AND REPLACED WITHOUT FURTHER INCIDENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4469

Patients

Seq Age Sex Outcome Treatment
1 74 YR (B)(4)| (B)(4)| (B)(4)